Related Experiment Video

Updated: Sep 28, 2026

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
09:23

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model

Published on: July 29, 2012

Chagas' heart disease: clinical-pathological correlation

Marcos A Rossi1, Simone G Ramos, Reynaldo B Bestetti

  • 1Department of Pathology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, S.P., Brazil. marossi@fmrp.usp.br

Frontiers in Bioscience : a Journal and Virtual Library
|November 29, 2002
PubMed

Insights

This review summarizes clinicopathological features of chronic Chagas' heart disease. It identifies mortality predictors to aid physicians in managing patients with Chagas' cardiomyopathy.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pathology

Background:

  • Chagas' disease, caused by *Trypanosoma cruzi*, is a significant public health concern.
  • Chronic Chagas' heart disease (cardiomyopathy) is a major cause of morbidity and mortality in endemic regions.
  • Understanding clinicopathological aspects and mortality predictors is crucial for effective patient management.

Purpose of the Study:

  • To review the clinicopathological characteristics of chronic Chagas' heart disease.
  • To provide a comprehensive overview of mortality predictors in patients with Chagas' cardiomyopathy.
  • To assist healthcare professionals in the clinical management of Chagas' heart disease.

Main Methods:

  • This study is a review of existing literature.
  • It synthesizes information on clinicopathological findings.
  • It analyzes data related to mortality predictors in Chagas' cardiomyopathy.

Main Results:

  • The review details key clinicopathological aspects of chronic Chagas' heart disease.
  • Several significant predictors of mortality have been identified for chagasic patients.
  • These findings highlight the complexity of the disease progression.

Conclusions:

  • Effective management of Chagas' heart disease requires understanding its clinicopathological features.
  • Identifying mortality predictors can guide therapeutic strategies and improve patient outcomes.
  • Further research into predictive markers may enhance clinical decision-making.

More Related Videos

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...